RefleXion's guided lung radiotherapy designated 'breakthrough'

By staff writers

December 1, 2021 -- RefleXion Medical's biology-guided radiotherapy (BgRT) has received a breakthrough device designation from the U.S. Food and Drug Administration for use in treating lung tumors.

The company envisages that with its technology, injected radiotracers produce active signals to guide delivery of treatment to each tumor present. In comparison, it is possible to reach only one to three tumors with available radiation techniques, RefleXion said.

Tumors in the lung are the most common cause of cancer-related death in the U.S. and the most common site of metastases.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking